Genomic biomarkers for chronic kidney disease

Translational Research

Volumn 159, Issue 4, 2012, Pages 290-302

  Ju, Wenjun ^a,b   Smith, Shahaan ^a   Kretzler, Matthias ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CREATININE; GENOMIC DNA; MICRORNA; MOLECULAR MARKER; NONSTEROID ANTIINFLAMMATORY AGENT; RNA; VASCULOTROPIN A;

CELL HETEROGENEITY; CHRONIC KIDNEY DISEASE; CREATININE CLEARANCE; DISEASE COURSE; FOCAL GLOMERULOSCLEROSIS; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC MARKER; GENETIC PREDISPOSITION; GLOMERULUS FILTRATION RATE; HIGH RISK PATIENT; HUMAN; INTRON; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY POLYCYSTIC DISEASE; NEPHROTIC SYNDROME; PATIENT CARE; PATIENT MONITORING; PHENOTYPE; PRIORITY JOURNAL; PROTEINURIA; RENAL REPLACEMENT THERAPY; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; STAGING; VALIDATION STUDY;

EID: 84863337741     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2012.01.020     Document Type: Review

References (72)

1. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework Clin Pharmacol Ther 2001 6989 6995
2. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification Am J Kidney Dis 39 2 Suppl 1 2002 S1 266
3. A.S. Levey, R.D. Perrone, and N.E. Madias Serum creatinine and renal function Annu Rev Med 39 1988 465 490
4. F. Kronenberg Emerging risk factors and markers of chronic kidney disease progression Nat Rev Nephrol 5 2009 677 689
5. C.M. O'Seaghdha, and C.S. Fox Genetics of chronic kidney disease Nephron Clin Pract 118 2011 c55 c63
6. M.W. Smith, and S.J. O'Brien Mapping by admixture linkage disequilibrium: advances, limitations and guidelines Nat Rev Genet 6 2005 623 632
7. J.B. Kopp, M.W. Smith, and G.W. Nelson MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis Nat Genet 40 2008 1175 1184
8. C.M. O'Seaghdha, R.S. Parekh, and S.J. Hwang The MYH9/APOL1 region and chronic kidney disease in European-Americans Hum Mol Genet 20 2011 2450 2456
9. S. Tzur, S. Rosset, and R. Shemer Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene Hum Genet 128 2010 345 350
10. G. Genovese, D.J. Friedman, and M.D. Ross Association of trypanolytic ApoL1 variants with kidney disease in African Americans Science 329 2010 841 845
11. B.J. Keller, S. Martini, J.R. Sedor, and M. Kretzler A systems view of genetics in chronic kidney disease Kidney Int 81 2012 14 21
12. A. Kottgen, C. Pattaro, and C.A. Boger New loci associated with kidney function and chronic kidney disease Nat Genet 42 2010 376 384
13. H.E. Wheeler, E.J. Metter, and T. Tanaka Sequential use of transcriptional profiling, expression quantitative trait mapping, and gene association implicates MMP20 in human kidney aging PLoS Genet. 5 2009 e1000685
14. B. Keller, S. Martini, J. Sedor, and M. Kretzler Linking variants from genome-wide association analysis to function via transcriptional network analysis Semin Nephrol 30 2010 177 184
15. K.I. Woroniecka, A.S. Park, D. Mohtat, D.B. Thomas, J.M. Pullman, and K. Susztak Transcriptome analysis of human diabetic kidney disease Diabetes 60 2011 2354 2369
16. H. Schmid, A. Boucherot, and Y. Yasuda Modular activation of nuclear factor-κB transcriptional programs in human diabetic nephropathy Diabetes 55 2006 2993 3003
17. M.A. Neusser, M.T. Lindenmeyer, and A.G. Moll Human nephrosclerosis triggers a hypoxia-related glomerulopathy Am J Pathol 176 2010 594 607
18. M.T. Lindenmeyer, M. Kretzler, and A. Boucherot Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy J Am Soc Nephrol 18 2007 1765 1776
19. W. Ju, F. Eichinger, and M. Bitzer Renal gene and protein expression signatures for prediction of kidney disease progression Am J Pathol 174 2009 2073 2085
20. K.S. Peterson, J.F. Huang, and J. Zhu Characterization of heterogeneity in the molecular pathogenesis of lupus nephritis from transcriptional profiles of laser-captured glomeruli J Clin Invest 113 2004 1722 1733
21. J.B. Hodgin, A.C. Borczuk, and S.H. Nasr A molecular profile of focal segmental glomerulosclerosis from formalin-fixed, paraffin-embedded tissue Am J Pathol 177 2010 1674 1686
22. M.R. Bennett, K.A. Czech, L.J. Arend, D.P. Witte, P. Devarajan, and S.S. Potter Laser capture microdissection-microarray analysis of focal segmental glomerulosclerosis glomeruli Nephron Exp Nephrol 107 2007 e30 e40
23. H.J. Baelde, M. Eikmans, P.P. Doran, D.W. Lappin, E. de Heer, and J.A. Bruijn Gene expression profiling in glomeruli from human kidneys with diabetic nephropathy Am J Kidney Dis 43 2004 636 650
24. M. Baker In biomarkers we trust? Nat Biotechnol 23 2005 297 304
25. A. Whelton, and C.W. Hamilton Nonsteroidal anti-inflammatory drugs: effects on kidney function J Clin Pharmacol 31 1991 588 598
26. Z. Stosic, V. Sedlak, D. Felle, S. Curic, M. Ubavic, and S. Vodopivec [Anti-proteinuria effects of nonsteroidal anti-inflammatory drugs in patients with nephrotic syndrome: an illusion or a read improvement?] Med Pregl 48 1995 155 158
27. A. Henger, M. Kretzler, and P. Doran Gene expression fingerprints in human tubulointerstitial inflammation and fibrosis as prognostic markers of disease progression Kidney Int 65 2004 904 917
28. N. Masuda, T. Ohnishi, S. Kawamoto, M. Monden, and K. Okubo Analysis of chemical modification of RNA from formalin-fixed samples and optimization of molecular biology applications for such samples Nucleic Acids Res 27 1999 4436 4443
29. R.A. Coudry, S.I. Meireles, and R. Stoyanova Successful application of microarray technology to microdissected formalin-fixed, paraffin-embedded tissue J Mol Diagn 9 2007 70 79
30. C.D. Cohen, H.J. Grone, E.F. Grone, P.J. Nelson, D. Schlondorff, and M. Kretzler Laser microdissection and gene expression analysis on formaldehyde-fixed archival tissue Kidney Int 61 2002 125 132
31. H. Schmid, A. Henger, and C.D. Cohen Gene expression profiles of podocyte-associated molecules as diagnostic markers in acquired proteinuric diseases J Am Soc Nephrol 14 2003 2958 2966
32. G. Wang, B.C. Kwan, and F.M. Lai Intrarenal expression of microRNAs in patients with IgA nephropathy Lab Invest 90 2010 98 103
33. G. Wang, B.C. Kwan, and F.M. Lai Intrarenal expression of miRNAs in patients with hypertensive nephrosclerosis Am J Hypertens 23 2010 78 84
34. Y. Dai, W. Sui, H. Lan, Q. Yan, H. Huang, and Y. Huang Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients Rheumatol Int 29 2009 749 754
35. M.W. Taal, and B.M. Brenner Predicting initiation and progression of chronic kidney disease: developing renal risk scores Kidney Int 70 2006 1694 1705
36. E.P. Bottinger TGF-β in renal injury and disease Semin Nephrol 27 2007 309 320
37. M. Suthanthiran, A. Khanna, and D. Cukran Transforming growth factor-β 1 hyperexpression in African American end-stage renal disease patients Kidney Int 53 1998 639 644
38. C.W. Yang, S. Hsueh, and M.S. Wu Glomerular transforming growth factor-β1 mRNA as a marker of glomerulosclerosis-application in renal biopsies Nephron 77 1997 290 297
39. M. Eikmans, H.J. Baelde, and E.C. Hagen Renal mRNA levels as prognostic tools in kidney diseases J Am Soc Nephrol 14 2003 899 907
40. Y. Yamaguchi, M. Iwano, and D. Suzuki Epithelial-mesenchymal transition as a potential explanation for podocyte depletion in diabetic nephropathy Am J Kidney Dis 54 2009 653 664
41. K.I. Samejima, K. Nakatani, and D. Suzuki Clinical Significance of Fibroblast-Specific Protein-1 Expression on Podocytes in Patients with Focal Segmental Glomerulosclerosis Nephron Clin Pract 120 2011 1 7
42. D. Alcorta, G. Preston, and W. Munger Microarray studies of gene expression in circulating leukocytes in kidney diseases Exp Nephrol 10 2002 139 149
43. G.A. Preston, I. Waga, and D.A. Alcorta Gene expression profiles of circulating leukocytes correlate with renal disease activity in IgA nephropathy Kidney Int 65 2004 420 430
44. S.N. Cox, F. Sallustio, and G. Serino Altered modulation of WNT-β-catenin and PI3K/Akt pathways in IgA nephropathy Kidney Int 78 2010 396 407
45. D.A. Alcorta, D.A. Barnes, and M.A. Dooley Leukocyte gene expression signatures in antineutrophil cytoplasmic autoantibody and lupus glomerulonephritis Kidney Int 72 2007 853 864
46. G.C. Linder, C. Lundsgaard, and D.D. Van Slyke The concentration of the plasma proteins in nephritis J Exp Med 39 1924 887 920
47. J.R. Delanghe, T.T. Kouri, and A.R. Huber The role of automated urine particle flow cytometry in clinical practice Clin Chim Acta 301 2000 1 18
48. S.U. Vogelmann, W.J. Nelson, B.D. Myers, and K.V. Lemley Urinary excretion of viable podocytes in health and renal disease Am J Physiol Renal Physiol 285 2003 F40 F48
49. M. Hara, T. Yanagihara, and T. Takada Urinary excretion of podocytes reflects disease activity in children with glomerulonephritis Am J Nephrol 18 1998 35 41
50. M. Hara, T. Yanagihara, M. Itoh, M. Matsuno, and I. Kihara Immunohistochemical and urinary markers of podocyte injury Pediatr Nephrol 12 1998 43 48
51. T. Nakamura, C. Ushiyama, and S. Suzuki Urinary podocytes for the assessment of disease activity in lupus nephritis Am J Med Sci 320 2000 112 116
52. T. Nakamura, C. Ushiyama, and S. Suzuki Urinary excretion of podocytes in patients with diabetic nephropathy Nephrol Dial Transplant 15 2000 1379 1383
53. B. Li, C. Hartono, and R. Ding Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine N Engl J Med 344 2001 947 954
54. C.C. Szeto, K.M. Chow, and K.B. Lai mRNA expression of target genes in the urinary sediment as a noninvasive prognostic indicator of CKD Am J Kidney Dis 47 2006 578 586
55. C.C. Szeto, R.W. Chan, and K.B. Lai Messenger RNA expression of target genes in the urinary sediment of patients with chronic kidney diseases Nephrol Dial Transplant 20 2005 105 113
56. B.C. Kwan, L.S. Tam, and K.B. Lai The gene expression of type 17 T-helper cell-related cytokines in the urinary sediment of patients with systemic lupus erythematosus Rheumatology (Oxford) 48 2009 1491 1497
57. M. Zheng, L.L. Lv, and J. Ni Urinary podocyte-associated mRNA profile in various stages of diabetic nephropathy PLoS One 6 2011 e20431
58. G. Wang, F.M. Lai, K.B. Lai, K.M. Chow, K.T. Li, and C.C. Szeto Messenger RNA expression of podocyte-associated molecules in the urinary sediment of patients with diabetic nephropathy Nephron Clin Pract 106 2007 c169 c179
59. C.C. Szeto, K.B. Lai, and K.M. Chow Messenger RNA expression of glomerular podocyte markers in the urinary sediment of acquired proteinuric diseases Clin Chim Acta 361 2005 182 190
60. M. Navarro-Munoz, M. Ibernon, and V. Perez Messenger RNA expression of B7-1 and NPHS1 in urinary sediment could be useful to differentiate between minimal change disease and focal segmental glomerulosclerosis in adult patients Nephrol Dial Transplant 26 2011 3914 3923
61. G. Wang, F.M. Lai, and L.S. Tam Urinary FOXP3 mRNA in patients with lupus nephritis-relation with disease activity and treatment response Rheumatology (Oxford) 48 2009 755 760
62. K. Tsugawa, E. Oki, K. Suzuki, T. Imaizumi, E. Ito, and H. Tanaka Expression of mRNA for functional molecules in urinary sediment in glomerulonephritis Pediatr Nephrol 23 2008 395 401
63. M. Zheng, L.L. Lv, and Y.H. Cao Urinary mRNA markers of epithelial-mesenchymal transition correlate with progression of diabetic nephropathy Clin Endocrinol (Oxford) 2011 10.1111/j.1365-2265
64. Y. Sato, B.L. Wharram, and S.K. Lee Urine podocyte mRNAs mark progression of renal disease J Am Soc Nephrol 20 2009 1041 1052
65. P.G. Moon, S. You, J.E. Lee, D. Hwang, and M.C. Baek Urinary exosomes and proteomics Mass Spectrom Rev 30 2011 1185 1202
66. M. Sika, J. Lewis, and J. Douglas Baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) Clinical Trial and Cohort Study Am J Kidney Dis 50 2007 78 89.e1
67. J.P. Lash, A.S. Go, and L.J. Appel Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function Clin J Am Soc Nephrol 4 2009 1302 1311
68. P.W. Mueller, J.J. Rogus, and P.A. Cleary Genetics of Kidneys in Diabetes (GoKinD) study: a genetics collection available for identifying genetic susceptibility factors for diabetic nephropathy in type 1 diabetes J Am Soc Nephrol 17 2006 1782 1790
69. D. Fliser, B. Kollerits, and U. Neyer Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study J Am Soc Nephrol 18 2007 2600 2608
70. E. Imai, S. Matsuo, and H. Makino Chronic Kidney Disease Japan Cohort (CKD-JAC) study: design and methods Hypertens Res 31 2008 1101 1107
71. K.U. Eckardt, B. Barthlein, and S. Baid-Agrawal The German Chronic Kidney Disease (GCKD) study: design and methods Nephrol Dial Transplant 2011 [Epub ahead of print].
72. S.L. Furth, S.R. Cole, and M. Moxey-Mims Design and methods of the Chronic Kidney Disease in Children (CKiD) prospective cohort study Clin J Am Soc Nephrol 1 2006 1006 1015